La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
AlzChem Group Résultats passés
Passé contrôle des critères 6/6
AlzChem Group has been growing earnings at an average annual rate of 17.5%, while the Chemicals industry saw earnings growing at 17.5% annually. Revenues have been growing at an average rate of 9.8% per year. AlzChem Group's return on equity is 25.5%, and it has net margins of 8.3%.
Informations clés
17.5%
Taux de croissance des bénéfices
17.5%
Taux de croissance du BPA
Chemicals Croissance de l'industrie | 12.4% |
Taux de croissance des recettes | 9.8% |
Rendement des fonds propres | 25.5% |
Marge nette | 8.3% |
Prochaine mise à jour des résultats | 07 Nov 2024 |
Mises à jour récentes des performances passées
Recent updates
A Look At The Intrinsic Value Of AlzChem Group AG (ETR:ACT)
Jun 04AlzChem Group's (ETR:ACT) Earnings Seem To Be Promising
May 08Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being
May 01AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 26Is AlzChem Group (ETR:ACT) A Risky Investment?
Apr 11AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20
Mar 29The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More
Mar 07Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching
Nov 01Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?
Oct 12AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
May 06AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment
May 05AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05
Apr 05AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
Mar 04AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year
Apr 24AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00
Mar 29AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00
Feb 27AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 23Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?
Jun 10At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?
Apr 07AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?
Mar 23AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price
Mar 10Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 24Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)
Feb 11Update: AlzChem Group (ETR:ACT) Stock Gained 13% In The Last Year
Aug 07Is Now An Opportune Moment To Examine AlzChem Group AG (ETR:ACT)?
Jul 20Does This Valuation Of AlzChem Group AG (ETR:ACT) Imply Investors Are Overpaying?
Jul 03Ventilation des recettes et des dépenses
Comment AlzChem Group gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Jun 24 | 557 | 46 | 161 | 0 |
31 Mar 24 | 546 | 39 | 155 | 0 |
31 Dec 23 | 546 | 35 | 149 | 0 |
30 Sep 23 | 528 | 30 | 145 | 0 |
30 Jun 23 | 549 | 28 | 141 | 0 |
31 Mar 23 | 570 | 30 | 140 | 0 |
31 Dec 22 | 550 | 30 | 139 | 0 |
30 Sep 22 | 534 | 29 | 136 | 0 |
30 Jun 22 | 487 | 28 | 135 | 0 |
31 Mar 22 | 454 | 27 | 134 | 0 |
31 Dec 21 | 429 | 28 | 133 | 0 |
30 Sep 21 | 420 | 27 | 135 | 0 |
30 Jun 21 | 406 | 26 | 133 | 0 |
31 Mar 21 | 397 | 23 | 129 | 0 |
31 Dec 20 | 386 | 20 | 129 | 0 |
30 Sep 20 | 370 | 16 | 127 | 0 |
30 Jun 20 | 389 | 17 | 127 | 0 |
31 Mar 20 | 387 | 17 | 127 | 0 |
31 Dec 19 | 385 | 18 | 125 | 0 |
30 Sep 19 | 389 | 19 | 124 | 0 |
30 Jun 19 | 380 | 18 | 122 | 0 |
31 Mar 19 | 380 | 20 | 120 | 0 |
31 Dec 18 | 383 | 23 | 118 | 0 |
30 Sep 18 | 380 | 22 | 114 | 0 |
30 Jun 18 | 398 | 32 | 123 | 0 |
31 Mar 18 | 364 | 21 | 115 | 0 |
31 Dec 17 | 361 | 20 | 114 | 0 |
30 Sep 17 | 356 | 22 | 115 | 0 |
31 Dec 16 | 333 | 15 | 111 | 0 |
30 Sep 16 | 331 | 12 | 108 | 0 |
31 Dec 15 | 329 | 15 | 106 | 0 |
31 Dec 14 | 298 | 14 | 98 | 0 |
31 Dec 13 | 302 | 17 | 93 | 0 |
Des revenus de qualité: ACT has high quality earnings.
Augmentation de la marge bénéficiaire: ACT's current net profit margins (8.3%) are higher than last year (5%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: ACT's earnings have grown by 17.5% per year over the past 5 years.
Accélération de la croissance: ACT's earnings growth over the past year (67.7%) exceeds its 5-year average (17.5% per year).
Bénéfices par rapport au secteur d'activité: ACT earnings growth over the past year (67.7%) exceeded the Chemicals industry 5%.
Rendement des fonds propres
ROE élevé: ACT's Return on Equity (25.5%) is considered high.